Reaction
Atrophy reporting signals
As of the last recalculation, Atrophy appears in 1,932 FAERS reports alongside 34 co-occurring drug terms. The strongest observed disproportionality signal is TRIAMCINOLONE ACETONIDE (PRR 17.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Triamcinolone Acetonide | 50 | 17.9 | 17.9 |
| Methylprednisolone Acetate | 11 | 14.9 | 14.9 |
| Cimetidine | 13 | 14.6 | 14.7 |
| Alendronate Sodium | 119 | 13.5 | 13.5 |
| Risedronate Sodium | 35 | 12.3 | 12.3 |
| Captopril | 10 | 11.3 | 11.3 |
| Trimethoprim | 12 | 11.0 | 11.0 |
| Zidovudine | 12 | 9.7 | 9.7 |
| Insulin Glulisine | 9 | 9.6 | 9.6 |
| Doxyclycline Hyclate | 15 | 9.6 | 9.6 |
| Hyoscyamine Sulfate | 8 | 9.4 | 9.4 |
| Phenobarbital | 11 | 8.2 | 8.2 |
| Faricimab | 6 | 8.0 | 8.0 |
| Phenytoin | 15 | 7.8 | 7.8 |
| Abacavir Sulfate | 7 | 7.8 | 7.8 |
| Thiotepa | 6 | 6.8 | 6.8 |
| Asfotase Alfa | 6 | 6.5 | 6.5 |
| Tenofovir Disoproxil Fumarate Tablets | 5 | 6.3 | 6.3 |
| Melphalan Hydrochloride | 14 | 6.1 | 6.1 |
| Daptomycin | 5 | 5.9 | 5.9 |
| Bupivacaine | 5 | 5.8 | 5.8 |
| Amantadine | 8 | 5.6 | 5.6 |
| Lamivudine Oral | 13 | 5.6 | 5.6 |
| Rivastigmine | 9 | 5.2 | 5.2 |
| Interferon Beta-1A | 87 | 5.0 | 5.0 |
| Clobazam | 11 | 4.9 | 4.9 |
| Glatiramer Acetate | 23 | 4.2 | 4.2 |
| Fingolimod Hcl | 30 | 3.8 | 3.8 |
| Peginterferon Beta-1A | 4 | 3.3 | 3.3 |
| Natalizumab | 51 | 3.1 | 3.1 |
| Dalfampridine | 20 | 3.0 | 3.0 |
| Onabotulinumtoxina | 21 | 3.0 | 3.0 |
| Tapentadol Hydrochloride | 9 | 2.9 | 2.9 |
| Ranibizumab | 6 | 2.4 | 2.4 |